We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
184 hedge funds and large institutions have $1.31B invested in Axsome Therapeutics in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 52 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 52
21% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 29
3% more funds holding
Funds holding: 179 → 184 (+5)
2.6% less ownership
Funds ownership: 64.22% → 61.62% (-2.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less capital invested
Capital invested by funds: $1.95B → $1.31B (-$643M)
74% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $53.6M
Holders
184
Holders Change
+5
Holders Change %
+2.79%
% of All Funds
3.23%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
35
Increased
64
Reduced
52
Closed
29
Calls
$14.1M
Puts
$53.6M
Net Calls
-$39.5M
Net Calls Change
-$34.1M
Top Buyers
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$24.4M |
| 2 |
Two Sigma Investments
New York
|
+$10.3M |
| 3 |
Morgan Stanley
New York
|
+$6.58M |
| 4 |
Millennium Management
New York
|
+$6.13M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.67M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$22.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$18.8M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$16.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$16.7M |
